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Summary A link between glucose transport and apoptosis was suggested. We studied
the mechanisms of glucose transport in human eosinophils by means of the uptake of
the positron emitting analogue, 18Fluoro-2-Deoxyglucose (FDG) and apoptosis by
means of flow cytometry. FDG uptake was inhibited by antibodies to GLUT1, 3 and 4
and by cytochalasin B. The anti-apoptotic principles IL-5, GM-CSF, IL-3 enhanced the
uptake, whereas the apoptosis-inducing principles anti-CD95 (anti-Fas) and exposure
to serum-coated Sephadex particles caused a reduction. Also TNF-a enhanced the
uptake. Other cytokines such as IL-2, IL-4, IL-8, RANTES and MCP-3 had no effect on
the glucose uptake. 2-Deoxyglucose, antibodies to GLUT4 and CD95 induced
apoptosis. The basal FDG-uptake was unaffected by PKC inhibitors Ro-31-8220, G .o-
6983 and G.o-6976, whereas the latter inhibited the IL-5-enhanced uptake possibly
due to the inhibition of PKCm. Protein tyrosine kinase and PI-3 kinase inhibitors
inhibited IL-5-enhanced FDG-uptake only. In contrast MEK inhibitors inhibited the
basal uptake only. Inhibitors of p38 MAPkinase inhibited both basal and IL-5 enhanced
uptake. We conclude that glucose uptake in eosinophils is governed by specific
intracellular mechanisms involving mobilization of GLUTs, Ca2þ and the activation of
the MAP kinase pathway and that the IL-5-enhanced uptake uniquely seems to involve
PKCm activity. Our results suggest a close link between apoptosis and glucose
transport in human eosinophils.
r 2003 Elsevier Ltd. All rights reserved.
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Introduction
The eosinophil granulocyte is an inflammatory cell
with potent biological capabilities of which the
cytotoxic activities are the most conspicuous.1 The
cytotoxic potential of eosinophils is related to the
production and secretion of a number of very basic
and cytotoxic proteins such as eosinophil cationic
protein (ECP) and major basic protein (MBP), but
also to the fact that the eosinophil is a very potent
producer of reactive oxygen species. It is generally
believed that the eosinophil is involved in parasite
killing, but possibly also in the killing of tumour
cells. Eosinophils are also involved in a number of
inflammatory diseases of which the best known is
bronchial asthma.
The attraction of eosinophils to sites of inflam-
mation and the subsequent activation of eosino-
phils at the site involves a complex network of
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different molecules and cellular interactions. How-
ever, some molecules seem to stand out as
particularly important and these are the cytokines
and chemokines. Thus, the cytokine interleukin-5
(IL-5) is of great importance in growth and
maturation of eosinophils as well as in the priming
and activation of mature cells.2 One example of the
importance of IL-5 are the experiments in which
antibody-inhibition of the activity of IL-5 in
broncho-alveolar lavage fluid obtained from aller-
gic asthmatics completely abrogated the capacity
of the fluid to attract eosinophils, although other
chemotactic principles were present in the fluid as
well.3 Another potentially very important effect of
IL-5 is anti-apoptosis. This effect of IL-5 is shared
with GM-CSF and IL-3 and is believed to contribute
to the accumulation of eosinophils in certain
inflammatory processes.4
Recent data have suggested a relationship
between apoptosis and glucose uptake.5–7 In one
study on a myeloid cell line, IL-3 was shown to
increase the uptake of glucose, and the induction
of apoptosis by interaction with the Fas-receptor
resulted in a prompt reduction in glucose uptake.8
Also in other cellular systems glucose uptake and
apoptosis seem to be related and have common
signal transduction pathways such as protein
tyrosine kinase activation.9 The aim of this study
was to investigate the mechanisms involved in
glucose transport in eosinophil granulocytes, since
such information is completely lacking and since
such knowledge might provide us with further
insight into the mechanisms involved in apoptotic
and anti-apoptotic mechanisms in these cells. For
this purpose we have studied the uptake of the
glucose analogue, 18Fluoro-2-Deoxyglucose (FDG),
which is a positron emitting compound. The
advantage of using this positron-emitting com-
pound for these purposes is the small number of
cells needed for each experiment. It is also of
importance to understand the biochemical me-
chanisms governing the uptake of FDG in inflam-
matory cells, since this radiotracer is increasingly
been used in the diagnosis of cancer and inflam-
matory processes.10,11
Material and methods
BAPTA/AM, G .o-6983, G.o-6976, Ro-31-8280, Genis-
tein, Wortmannin, Calyculin A, PD 98059,
Ly294002, SB 203580 were all purchased from
Calbiochem. Antibodies to GLUT1-5 were pur-
chased from Alpha Diagnostic International (USA).
Anti-CD95 (clone CH-11) was from Immunotech
(France). Dexamethasone and methyl prednisolone
were from Pharmacia Corporation (USA).
The cytokines IL-2, IL-3, IL-4, IL-5, IL-8, GM-CSF,
RANTES, MCP-3, TNF-a were all purchased from
R&D (USA).
Serum-coated Sephadex-particles were prepared
as described previously.12
18FDG was produced using the GE PETtrace FDG
MicroLab unit from GEMS PET Systems, which is an
automated radiochemistry system for the produc-
tion of 2-[18F]-fluoro-2-2-Deoxyglucose from [18F]-
fluoride utilizing the process described by Toor-
ongian et al.13
Eosinophils were isolated from the blood healthy
individuals as previously described.14 Briefly, mono-
nuclear leukocytes were removed by separation
using Percoll gradient centrifugation and the
eosinophils were separated from the neutrophils
by negative immunoselection using anti-CD16
coated particles (Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany). Neutrophils were purified by
positive immunoselection using anti-CD16 coated
particles. The purity of both cell types was 498%.
The uptake studies of 18FDG in eosinophils or
neutrophils was performed as follows: 100 ml of a
cell suspension containing 0.5 106 cells/ml was
mixed with 25 ml of 18FDG (final concentration on
average 0.2 mmol/l) in the presence of a final
concentration of glucose of 0.2mmol/l. After this
100 ml phosphate buffered saline was added con-
taining stimulators and/or inhibitors at indicated
concentrations. The final incubation volume was
225 ml containing 50 000 cells. The mixture was
allowed to incubate for 40min in most experiments
after which the cells were washed by centrifuga-
tion 6 times with 2ml of PBS each time. When
enhancers and inhibitors were used these were co-
incubated with the mixture for 40min unless
otherwise indicated in the results section. The
radioactivity in the cell pellet was subsequently
counted in a gamma counter. Because of the rapid
decay of 18FDG a reference was counted in parallel
and the counts adjusted automatically.
Apoptosis of eosinophils was evaluated by flow
cytometry.15 The eosinophils, 1 109/l, were cul-
tured in 96-well tissue culture plates in a medium
consisting of RPMI-1640 medium (Life Technologies,
Paisley, Scotland), 20% FCS (Life Technologies), L-
glutamine (2mmol/l) (Biochrom KG, Berlin, Ger-
many), penicillin (100 IU/ml) and streptomycin
(100 mg/ml) (Biochrom KG) in 5% CO2 at 371C. The
cells were co-cultured with 2-deoxyglucose (0.5–
20mmol/l) and with antibodies to GLUT1, 2, 3 and
4 (5 mg/ml) and CD95 (2 mg/ml), respectively, for
24 h After culture, the eosinophils were aliquoted
into tubes and incubated for 30min on ice with FDA
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(0.17mg/l) (Sigma-Aldrich, St. Louis, MI, USA) or
Annexin V (PharMingen, San Diego, CA, USA). Then,
the cells were washed with PBS containing 0.5% (w/
v) BSA and analysed by flow cytometry. The flow
cytometer used was a Coulter EPICS XL-MCL
(Coulter Company Inc., Miami, FL, USA). Instru-
ment calibration was performed daily according to
the recommendation of the manufacturer. On
average, 10 000 cells from each sample were
analysed in the flow cytometer. The relative
number of incubated for 30min on ice with FDA
(0.17mg/l) (Sigma-Aldrich, St. Louis, MI, USA) or
Annexin V (PharMingen, San Diego, CA, USA). Then,
the cells were washed with PBS containing 0.5% (w/
v) BSA and analysed by flow cytometry. The flow
cytometer used was a Coulter EPICS XL-MCL
(Coulter Company Inc., Miami, FL, USA). Instru-
ment calibration was performed daily according to
the recommendation of the manufacturer. On
average, 10 000 cells from each sample were
analysed in the flow cytometer. The relative numbd
Software (San Diego, California USA).
Results
Basal and cytokine-induced uptake of FDG
FDG is spontaneously taken up by the eosinophil
and the uptake increased linearly with time as is
shown in Fig. 1a. The effects of increasing
concentrations of glucose in the medium are shown
in Fig. 1b. At the concentration of 0.6mM glucose
the uptake was inhibited by 50% (IC50). For
comparison the basal uptake of FDG in normal
human neutrophils is also shown and was in most
experiments two to three times as high as the
uptake in eosinophils. Also the inhibitory effect of
external glucose on neutrophil FDG-uptake is
shown. The IC50 on the neutrophil uptake was
about 0.2mM glucose. These data suggest differ-
ences in the glucose transport mechanisms be-
tween eosinophils and neutrophils.
The incubation of eosinophils with the growth
factors IL-5, GM-CSF or IL-3 resulted in a dose
dependent enhancement of the FDG-uptake
(Fig. 2), whereas the effects of a number of other
cytokines were absent, such as for IL-2, IL-4, IL-8,
RANTES and MCP-3. In most experiments the
enhancement of the FDG-uptake was the highest
for IL-5 followed by GM-CSF, whereas the uptake
induced by IL-3 was increased, but at a lower level.
Maximal enhancement with IL-5 was achieved at
concentrations of 500 ng/106 eosinophils and no
further enhancement was achieved by the addition
of GM-CSF at maximal concentrations (data not
shown). Nor did preincubation with IL-5 at con-
centrations of 5 ng/106 eosinophils for 30min at
371C result in any stimulatory effects of any of the
above-mentioned cytokines. Also the incubation
with TNF-a caused a dose related enhancement
with optimal concentrations at 50 ng/106 eosino-
phils (Fig. 2). For comparison we incubated
eosinophils with a strong secretagogue, serum-
coated Sephadex particles. This incubation re-
sulted in a dose related strong inhibition of the
basal FDG-uptake (Fig. 3).
ARTICLE IN PRESS
Incubation time, minutes
0 20 40 60 80 100 120 140
FD
G
 u
pt
ak
e,
 p
er
ce
nt
0
200
400
600
800
1000
1200
1400
Glucose, mmol/L
0.01 0.1 1 10
CP
M
1e+2
1e+3
1e+4
1e+5
1e+6
Eosinophils
Neutrophils
IC50 eosinophils = 0.60 mmol/Lglucose
IC50 neutrophils = 0.25 mmol/L glucose
(a)
(b)
Figure 1 (a) The basal uptake of FDG in normal
eosinophils as a function of time. The eosinophils were
incubated with FDG for various times after which the
cells were washed and the radioactivity in the pellet
measured. The results are expressed as % of the FDG-
uptake at 10minutes incubation. (b) The effect of
glucose on the basal uptake of FDG in normal eosinophils
and neutrophils. The purified cells were incubated with
FDG for 40min in the presence of increasing concentra-
tions of glucose in the buffer. After incubation the cells
were washed and the radioactivity in the pellet mea-
sured. The IC50 (the concentration of glucose that gives a
50% inhibition of the FDG uptake) is indicated on the
figure. The results are given as cpm (counts per minute).
The results shown are representative of three experi-
ments with almost identical results.
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Glucose transporters in human eosinophils
In Table 1 the effects of cytochalasin B on basal and
IL-5-enhanced FDG-uptake is shown. The results
show that Cytochalasin B almost completely pre-
vented any uptake of FDG. This suggests the
involvement of GLUTs in the transporter process,
since Cytochalasin B was shown to be a potent
blocker of GLUTs.16 In order to study the role of
GLUTs in the transport and uptake of FDG into the
eosinophils further, we used monoclonal antibodies
against GLUT 1–5 to block the activity of the GLUT
molecules. The results are shown in Fig. 4.
Antibodies against GLUT 1, 3 and 4 inhibited FDG
uptake in a dose-dependent manner, with anti-
bodies against GLUT4 being the most potent,
whereas the effects of antibodies against GLUT 2
and 5 were minor or absent. This pattern was seen
both with basal uptake of FDG as well as with IL-5
enhanced uptake (data not shown).
Induction of apoptosis
Eosinophils were cultured in the presence of
increasing concentrations of the glucose analogue
2-Deoxyglucose. After 24 h of culture in the
presence of41mmol/l 2-Deoxyglucose the propor-
tion of FDA positive cells was progressively
decreased indicating reduced viability, while the
proportion of Annexin V positive cells progressively
increased as a sign of apoptosis-induction (Fig. 5).
The experiment confirms the notion that glucose
deprivation induces apoptosis.17,18
In the next set of experiments eosinophils were
cultured in the presence of various GLUT-antibodies
and the relative amount of apoptotic eosinophils
was measured after 24 h. Co-culture with anti-
bodies to GLUT4 partially and markedly increased
the relative number of Annexin V positive, apopto-
tic cells, whereas antibodies to GLUTs 1, 2 and 3
had no effect (Fig. 6). Furthermore, co-culture
with anti-CD95, as might be expected,5 induced
apoptosis and to a similar extent as anti-GLUT4. In
parallel the proportion of FDA positive, viable,
eosinophils was markedly reduced by co-culture
with anti-GLUT4 and anti-CD95 (54% and 40% versus
71%), but not with anti-GLUT1, 2 and 3.
Modification of the FDG uptake by various
inhibitors of intracellular signal transduction
pathways
In order to study the intracellular transduction
signals involved in both basal and IL-5 enhanced
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Figure 2 The effects of IL-3 (n ¼ 3), IL-5 (n ¼ 6), GM-
CSF (n ¼ 3) and TNF-a (n ¼ 4) on FDG-uptake in normal
human eosinophils. The eosinophils were incubated
together with FDG and the respective cytokine at
indicated concentrations for 40min after which the cells
were washed and the radioactivity in the pellets
measured. Results are presented as % of control, i.e.
the basal FDG-uptake in buffer medium and as means and
SEM. For all cytokines the uptake was increased, as
compared to buffer only, in all experiments at the
optimal concentrations, which were 500 ng/106 cells for
IL-3, IL-5 and GM-CSF and 50 ng/106 cells for TNF-a.
Significant effects were calculated by repeated measures
ANOVA and the statistics are indicated in the figure.
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Figure 3 FDG-uptake in normal eosinophils after the
exposure of the cells to serum-coated Sephadex-parti-
cles. The cells were incubated with FDG and particles at
decreasing concentrations for 40min after which the
cells were washed and the radioactivity measured.
Results are presented as % of control, i.e. the basal
FDG-uptake in buffer medium and the median of four
experiments and highest values at each concentration.
Significant effects were calculated by repeated measures
ANOVA and the statistics are indicated in the figure.
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FDG-uptake we made a survey using a number of
inhibitors of key activities.
(a) The basal or IL-5 enhanced FDG uptake was not
inhibited by EDTA (not shown), but by the
intracellular Ca-chelator BAPTA/AM (Table 2),
which indicates that intracellular changes in
Caþ þ are involved.
(b) To study the involvement of Protein kinase C
(PKC) we incubated the eosinophils with
various inhibitors such as Ro-31-8220, G .o-6976
and G.o-6983. The inhibitors were chosen to
cover most of the known activities of the PKC
isoenzyme (Calbiochem, Signal Transduction
Catalog & Technical Resources, 1999, p.
305).Ro-31-8220 or G .o-6983 did not affect the
basal nor the IL-5 enhanced FDG uptake at
concentrations from 108 to 105mol/l. G.o-
6976 did not affect the basal FDG uptake,
whereas the IL-5 enhanced uptake was inhib-
ited in a dose dependent manner with a
complete inhibition at 105mol/l (Fig. 7a).
These data suggest that PKC activation is not
involved in the basal uptake of FDG, whereas
activation of PKC-m is suggested to be involved
in the IL-5 enhanced FDG-uptake.19
(c) The involvement of tyrosine kinase activity was
studied by means of Genistein.Genistein in-
hibited the basal FDG uptake by about 25% but
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Table 1 FDG-uptake by eosinophils and the effects of cytochalasin B.
Basal FDG-uptake (%) IL-5 enhanced FDG-uptake (%)
Exp 1 Exp 2 Exp 1 Exp 2
Cytochalasin B 10 mg/ml 2.5 2.1 2.5 1.8
2mg/ml 11.0 8.0 12.1 9.7
Control 100 100 152 160
Eosinophils were incubated for 40min with cytochalasin B together with FDG and either buffer or IL-5 (500 ng/106 eosinophils),
after which the cells were washed and the uptake was measured. Results are presented as % of control, i.e. the basal FDG-
uptake in buffer medium.
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Figure 5 The effect of 2-Deoxyglucose on eosinophil
apoptosis and viability as measured by relative numbers
of Annexin V- and FDA-positive eosinophils. Eosinophils
were cultured in the presence of 2-deoxyglucose (0.5–
20mmol/l) for 24 h, then the cells were washed and the
number of Annexin V- and FDA-positive cells, respec-
tively, was measured by flow cytometry. The figure shows
the medians of two experiments. Significant effects were
calculated by repeated measures ANOVA and the statis-
tics are indicated in the figure.
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Figure 4 The effects of various GLUT antibodies on the
basal FDG-uptake in normal eosinophils. The cells were
incubated with FDG and GLUT antibodies 1–5 at decreas-
ing concentrations for 40min after which the cells were
washed and the radioactivity in the pellet measured.
The symbols for the different antibodies are given on the
figure. Results are presented as % of control, i.e. the
basal FDG-uptake in buffer medium in the absence of any
antibodies. The results are medians three experiments.
Significant effects were calculated by repeated measures
ANOVA and the statistics are indicated in the figure.
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only at the highest concentration, i.e.
105mol/l. In contrast the IL-5 induced en-
hancement was inhibited in a dose dependent
manner and completely at 105–106mol/l
(Fig. 7b). The results suggest the involvement
of protein tyrosine kinase activity in the IL-5
enhanced FDG-uptake.
(d) The two specific inhibitors of PI-3 kinase
activity, Wortmannin and Ly 294002 did not
affect the basal FDG uptake. The IL-5 enhanced
uptake was inhibited in a dose dependent
manner with an almost complete inhibition at
106–107mol/l (Fig. 7c and Table 2), suggest-
ing the involvement of PI-3 kinase activity in
this enhancement, but not in the basal uptake
of FDG.
(e) The MEK inhibitor PD 098059 inhibited the
basal FDG uptake by about 25% at 105mol/l.
The IL-5 enhanced uptake (Table 2) was
inhibited to the same extent and was likely
attributed to the inhibition of the basal FDG
uptake. Thus an inhibitory activity specifically
directed towards the IL-5 enhanced part of the
uptake was not suggested by the experiments.
In contrast the specific inhibitor of the p38
MAPkinase, i.e. SB 203580, was a potent
inhibitor of both basal and IL-5-enhanced
glucose uptake (Fig. 7d). Our results therefore
suggest that MEK is involved in the basal uptake
of FDG only, whereas the p38 MAPkinase may
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Figure 6 The effects of various anti-GLUTantibodies and
anti-CD95 on eosinophil apoptosis as measured by
number of Annexin V-positive cells. Eosinophils were
cultured with 5 mg/ml of antibodies to GLUT1, 2, 3 and 4
and with anti-CD95 (2 mg/ml), respectively, for 24 h. After
that the cells were washed and the number of Annexin V-
positive cells was measured by flow cytometry. The figure
shows the medians and ranges of three experiments.
Significant effects were obtained with anti-GLUT4 and
anti-CD95 as calculated by paired Students t-test.
Table 2 FDG-uptake by eosinophils and the effects of various inhibitors of intracellular transduction pathways.
Compound (mol/l) Basal FDG-uptake (%) IL-5 enhanced FDG-uptake (%)
Exp 1 Exp 2 Exp 1 Exp 2
BAPTA/AM 2.5 105 18 4.3 22 4.7
105 80 6.6 63 8.5
106 125 109 148 95
107 127 na 160 Na
0 100 100 146 150
LY294002 105 85 95 92 94
106 88 83 136 133
107 108 85 133 150
0 100 100 151 168
PD098059 105 75 70 125 110
106 118 109 160 156
107 97 105 152 162
0 100 100 166 146
Calyculin A 107 47 na 47 Na
108 63 34 (2 ) 60 35 (2 )
109 89 93 (2 ) 131 102 (2 )
1010 109 98 (2 ) 128 117 (2 )
0 100 100 (2 ) 132 118 (2 )
The respective inhibitor was incubated together with FDG and buffer (basal uptake) or IL-5 (500 ng/106 eosinophils) (Il-5
enhanced uptake) for 40min after which the cells were washed and radioactivity in the pellet measured. Results are presented
as % of control, i.e. the basal FDG-uptake in buffer medium.na¼ not applicable; (2 ) indicates that these experiments were
performed with two times higher concentrations of calyculin A.
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be involved in both the basal and IL-5 enhanced
uptake.
(f) The phosphatase inhibitor Calyculin A potently
inhibited both the basal and the IL-5 enhanced
FDG uptake at concentrations from 108mol/l
(Table 2) confirming the importance of phos-
phorylation processes in the glucose transpor-
ter processes.
Effects of other inhibitors
Since a relationship between apoptosis induction
and glucose transport has been suggested8 and
further suggested above, we studied the effects of
two mechanisms possibly involved. One is the
interaction with the Fas-receptor5 and the other
is the effect of corticosteroids.20,21
Preincubation of eosinophils with monoclonal
antibodies to the Fas-receptor, i.e. anti-CD95, for
120min caused a dose dependent reduction in
the basal FDG uptake (Fig. 8). Pre-incubation of the
cells for 50min with either Dexamethason in the
concentration range from 107–109mol/l or
Methylprednisolone in the concentration range
from 106–108 did not affect either the basal
FDG uptake nor the IL-5 enhanced uptake (data not
shown). These data indicate that induction of
apoptosis by anti-Fas reduces the uptake of FDG,
whereas no effects of corticosteroids were dis-
cernible.
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Figure 7 (a)–(d) The effects of various inhibitors of intracellular signal transduction pathways on the FDG-uptake in
normal eosinophils. (a) The cells were incubated with FDG and the PKC-inhibitors Ro-31-8220, G .o-6983, G.o-6976, at
increasing concentrations (108–105mol/l) for 40min in the absence (basal uptake) or presence of IL-5 (500 ng/106
eosinophils) (IL-5 enhanced uptake) after which the cells were washed and the radioactivity in the pellet measured. The
symbols for the different inhibitors are given in the figure. (b) The cells were incubated with FDG and the protein
tyrosine kinase inhibitor Genistein at increasing concentrations (108–105mol/l) for 40min in the absence (basal
uptake) or presence of IL-5 (500 ng/106 eosinophils) (IL-5 enhanced uptake) after which the cells were washed and the
radioactivity in the pellet measured. (c) The cells were incubated with FDG and the PI-3 kinase inhibitor Wortmannin at
increasing concentrations (1010–106mol/l) for 40min in the absence (basal uptake) or presence of IL-5 (500 ng/106
eosinophils) (IL-5 enhanced uptake) after which the cells were washed and the radioactivity in the pellet measured. (d)
The cells were incubated with FDG and the p38 MAP kinase inhibitor SB 203580 at increasing concentrations (107–
105mol/l) for 40min in the absence (basal uptake) or presence of IL-5 (500 ng/106 eosinophils) (IL-5 enhanced uptake)
after which the cells were washed and the radioactivity in the pellet measured. Results are presented as % of control,
i.e. the basal FDG-uptake in buffer medium. The results shown are medians of three experiments. Significant effects
were calculated by repeated measures ANOVA and the statistics are indicated in the figure.
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Discussion
Our results have shown that 18FDG may be used as a
substitute for glucose in the study of glucose
transporter mechanisms in eosinophils and neutro-
phils, since the uptake of 18FDG was clearly
dependent on glucose transporter molecules, i.e.
GLUT, and since glucose competed with the uptake
of 18FDG. This conclusion is in agreement with that
of others using other cell systems17 and the use of
18FDG as an in vivo tool in the detection of
metabolically active tissues.10,11 One advantage
of using FDG as a tool to study glucose uptake was
the minimum requirement of cells, in particular
when one is studying purified eosinophils. Although
we used 50 000 cells as standard in our incubations,
the use of less than one-tenth of this number, i.e.
to less than 5000 cells per incubation, would have
been possible. It was suggested by our results that
eosinophils and neutrophils use partly different
mechanisms for the basal uptake of 18FDG and that
the affinity of 18FDG to the eosinophil glucose
transporter mechanisms was about three times
higher than for the neutrophils. On the other hand
the basal uptake of 18FDG in neutrophils was
consistently higher than that seen for normal
eosinophils. Earlier reports showed a similar rate
of metabolism of 14C-glucose for normal eosinophils
and neutrophils, whereas the rate was much higher
in eosinophils obtained from patients with eosino-
philia.22 Also the uptake of 2-Deoxyglucose was
much higher in such eosinophils, which may be
compatible with our results on growth factor
stimulated 18FDG uptake. It should be emphasized
that the uptake of 18FDG only reflects the actual
transport of glucose across the plasma membrane
and not glucose metabolism, since 18FDG is not
metabolised further, but bound irreversibly to
hexokinase.10,23 Therefore, the comparison of
results of uptake and those of actual metabolism
of glucose is difficult. The dependence on glucose
transporters for the uptake of 18FDG was suggested
by the potent inhibition by cytochalasin B 16 of both
the basal and the IL-5 enhanced uptake, but also by
the inhibition of glucose uptake by antibodies to
the various GLUTs. The fact that antibodies to
either GLUT 1, 3 or 4 at the highest concentrations
almost completely inhibited the 18FDG uptake
suggested that these molecules cooperate or that
these three glucose transporter molecules share
common epitopes involved in the glucose transport.
It should be emphasized that the inhibitory effects
of the three GLUT antibodies were similar whether
basal glucose or IL-5 enhanced glucose uptake was
studied, indicating that these molecules are op-
erative in both situations. The presence of GLUT4
may be surprising, since this is the GLUT molecule
normally regulated by insulin9 and since it is
assumed that glucose uptake by eosinophils is
independent of insulin. In preliminary studies we
could not find any effect of insulin on 18FDG uptake
in eosinophils supporting this notion. The absent
effect of GLUT5 may be explained by the fact that
this transporter molecule is operative preferen-
tially in fructose transport and the absent effect of
GLUT2 by the fact that it has been shown to have a
much lower affinity for glucose than the other
GLUTs.16,24 In preliminary flow cytometry studies,
though, all five GLUTs were found to be present in
eosinophils when saponin was used to permeabilize
the cells.
The enhancement of glucose uptake by IL-3 and
GM-CSF has been shown in neutrophils, T-lympho-
cytes and some cell lines, whereas the effects on
eosinophils have not been documented.8,25,26 We
found that IL-5 in addition to those two growth
factors and in addition to TNF-a uniquely enhanced
glucose uptake, since other cytokines (e.g.
RANTES, MCP-3), with agonist effects on eosino-
phils, had no effect. This implies that the glucose
transporter mechanisms are related to growth,
survival and priming of eosinophils rather than to
effector functions such as secretion, migration,
etc., although glucose is the major energy
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Figure 8 The effects of anti-CD95 (anti-Fas) on the
uptake of FDG in normal eosinophils. The cells were
preincubated with the apoptosis inducing antibody anti-
CD95 (anti-Fas) for 120min at 371C at increasing
concentrations (0.1–2 mg/ml) after which FDG was added
and the mixture incubated for further 40min. After this
the cells were washed and the radioactivity in the pellet
measured. Results are presented as % of control, i.e. the
basal FDG-uptake in buffer medium and as medians and
range of four experiments. Significant effects were
calculated by repeated measures ANOVA and the statis-
tics are indicated in the figure.
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substrate for such activities. It is therefore of
interest that molecules with opposite actions to
these growth factors, i.e. principles, which induce
apoptosis, such as anti-CD95, at the same time
reduce glucose transport. Moreover, a classical
stimulus for degranulation, i.e. complement coated
particles, actually reduced the basal 18FDG-uptake.
This latter finding may be an example of the
induction of apoptosis, since earlier workers
showed that induction of eosinophil degranulation
induced signs of apoptosis in the cells.27 Since other
studies have indicated an apoptosis inducing effect
of glucocorticosteroids on eosinophils,20,21 we
expected to find an adverse effect of these
compounds on the 18FDG-uptake. Our failure of
showing such an adverse effect of glucocorticoster-
oids, however, may be due to the short-term
incubations. For unknown reasons long-term ex-
periments with incubations of eosinophils with
glucocorticosteroids, i.e. for 20 h, showed very
inconsistent results and any conclusions from these
were not possible to draw. Thus, any effect of
glucocorticosteroids on the 18FDG-uptake cannot
be entirely excluded.
The link between glucose uptake in eosinophils
and apoptosis was indeed suggested by our findings
that glucose deprivation by the incubation of the
eosinophils with the competitor molecule 2-Deox-
yglucose potently induced apoptosis. The depen-
dence on glucose uptake was also indicated by the
inhibitory effects of antibodies against GLUT4. Our
findings on eosinophils, therefore, parallel the
findings in several other cellular systems.5,7,17,28
Surprisingly, though the other GLUT-antibodies
were without effect, although they inhibited
glucose uptake as noted above. Differences in
potencies when it comes to the induction of
apoptosis, however, maybe a matter of quantita-
tive differences rather than qualitative differ-
ences, since the GLUT4 antibodies consistently
were more potent in the inhibition of glucose
uptake.
The signal transduction mechanisms involved in
basal and IL-5 enhanced uptake were studied by the
use of a range of inhibitors of key activities. Our
results showed the pivotal role of intracellular
calcium for both the spontaneous and IL-5 en-
hanced uptake, whereas depletion of extra cellular
calcium was without any effect. Earlier studies
have established that the expression of mRNA for
GLUT1 in liver and muscle cells and the mobiliza-
tion of the protein to the cell membrane are
dependent on intracellular calcium.29 However, no
information is available as to the dependence of
calcium for glucose transport into eosinophils or
other myeloid cells. It is interesting though, that
chelation of intracellular calcium promoted apop-
tosis of neutrophils,30 thus emphasizing the likely
link between glucose transport and apoptosis.
The results obtained in this study clearly indi-
cated that the spontaneous, basal uptake of
glucose from the environment and the growth
factor enhanced uptake are governed by different
intracellular signals. Thus, the effects of various
putative inhibitors of protein kinase C indicated
that the basal glucose uptake is independent of
these pathways in the meaning that no inhibitions
were seen with any of the inhibitors used. The IL-5
enhanced uptake was also unaffected by most PKC
inhibitors, with the exception of the inhibitor G.o-
6976. G .o-6976 is a general inhibitor of Ca2þ
dependent PKCs, but as opposed to the other
general inhibitors, it uniquely inhibits the m-isoform
of PKC.31 Consequently, our interpretation is that
PKCm may be involved in growth factor enhanced
uptake of glucose. A similar observation was made
in a murine mast cell model of allergen-stimulated
cells, in which the effects of IL-5 and TNF-a were
shown to be dependent on PKCm.32 PKCm was also
suggested to be involved in IL-6-dependent prolif-
eration of murine plasmacytoma cells.19 This novel
finding in human eosinophils may therefore be an
interesting target for future drug development.
The involvement of tyrosine kinase and PI-3
kinase activities in IL-5 enhanced, but not in basal
glucose uptake, was suggested by the results in this
study. These findings are compatible with earlier
observations that IL-5 priming of eosinophils in-
cludes such activities.33 Also, the findings that the
increased transporter affinity for glucose in other
myeloid cells, as promoted by IL-3, was reduced by
such inhibitors support our findings.34 The relation-
ship between glucose uptake and apoptosis is
further suggested by these experiments, since
inhibitors of PI-3 kinase prevented glucose uptake
and induced apoptosis.35 Earlier work, however,
showed a relationship between Fas-induced apop-
tosis and MAPkinase activity in the human leukemic
T cell line, Jurkat with a reduction in apoptotic
cells after incubation with PD 098059,36 whereas in
our experiments PD 098059 seemed to have little
effect on IL-5 enhanced glucose uptake, but
inhibited the basal uptake. The explanation to
these seeming discrepancies could be due to the
fact that different mechanisms are operative in
different cells, although others have shown the
dependence of MAPkinase activity for IL-5 and GM-
CSF activation of eosinophils.37 Indeed we showed
in this report that the p38 MAPkinase seems to be
involved in IL-5 enhanced glucose uptake.
Which might be the actual link between
reduced glucose transport and apoptosis in human
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eosinophils? Triggering of the mitochondrial death
cascade by intracellular depletion of ATP is one
common mechanism in most other cells. Eosino-
phils, however, are almost lacking mitochondria
and any oxidative phosphorylation does not take
place in this cell. These data would imply that the
involvement of mitochondria in apoptosis induction
in eosinophils is less likely. However, recent studies
have suggested that the few remaining mitochon-
dria in eosinophils actually have preserved their
apoptotic function, but not their respiratory func-
tion.38 Thus, lowering of intracellular ATP as a
consequence of reduced glucose transport and
glycolysis seems to be a reasonable hypothesis as
to the mechanism of the induction of apoptosis also
in human eosinophils.
We conclude that glucose uptake in eosinophils is
dependent on the glucose transporter molecules 1,
3 and 4, and that molecules which are anti-
apoptotic enhance this uptake and that apoptotic-
inducing principles such as anti-Fas may reduce this
uptake. We also confirm that, like in other cellular
systems, blockage of glucose uptake induces
apoptosis of eosinophils. Glucose uptake in eosino-
phils seems to be dependent on mobilization of
intracellular Ca2þ and the MAP kinase pathway.
The IL-5-enhanced uptake is initiated through
mechanisms involving protein tyrosine kinase activ-
ity, PI-3 kinase and PKCmU A close link between
apoptosis and glucose transport in human eosino-
phils is suggested.
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